Ad is loading...
RDWGX
Price
$10.66
Change
-$0.07 (-0.65%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

RDWGX vs RNWFX

Header iconRDWGX vs RNWFX Comparison
Open Charts RDWGX vs RNWFXBanner chart's image
American Funds Dvlpg Wld Gr&Inc R6
Price$10.66
Change-$0.07 (-0.65%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
RDWGX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RDWGX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RDWGX is a Sell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. RDWGX (1.82B). RDWGX pays higher dividends than RNWFX: RDWGX (2.01) vs RNWFX (1.51). RDWGX was incepted earlier than RNWFX: RDWGX (11 years) vs RNWFX (23 years). RDWGX is a more actively managed with annual turnover of: 37.00 vs. RNWFX (32.00). RDWGX (250) and RNWFX (250) have matching initial minimum investment requirements. RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. RDWGX (9.59). RNWFX return over 5 years is better than : 17.17 vs. RDWGX (4.23).
RDWGXRNWFXRDWGX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years23 years-
Gain YTD4.4917.09963%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.82B60.9B3%
Annual Yield % from dividends2.011.51134%
Returns for 1 year9.5911.5483%
Returns for 3 years-16.45-14.55113%
Returns for 5 years4.2317.1725%
Returns for 10 years7.6041.0019%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics